2018.02.08PDF(194KB)
Announcement of Establishment of New Company
2018.02.06PDF(276KB)
Hisamitsu Pharmaceutical, Becomes an Official Partner (External Pain Relief Products) of the Olympic and Paralympic Games Tokyo 2020!
2018.01.31PDF(110KB)
Notification of the results of the Phase III clinical study of HP-3070 (transdermal patch for the treatment of schizophrenia) in the US
2018.01.19PDF(115KB)
Notification of the approval of a manufacturing and marketing for ALLESAGA® TAPE (Development Code: HP-3060) in Japan, a transdermal system for the treatment of allergic rhinitis.
2018.01.12
FY02/2018 Q3 Results Earnings Release Presentation